Lynparza Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Hard capsule: Each capsule contains 50 mg of olaparib.
FC tablet: Each 100 mg film-coated tablet contains 100 mg of olaparib.
Each 150 mg film-coated tablet contains 150 mg of olaparib.
Excipients/Inactive Ingredients: Hard capsule: Capsule Content: Lauroyl macrogol-32 glycerides.
Capsule Shell: Hypromellose, Titanium dioxide (E171), Gellan gum (E418), Potassium acetate.
Printing Ink: Shellac, Iron oxide black (E172).
FC tablet: The names of inactive ingredients may vary according to region.
Core: Copovidone, Colloidal silicon dioxide, Mannitol, Sodium stearyl fumarate.
Tablet coating: Hypromellose, Macrogol 400, Titanium dioxide (E171), Iron oxide yellow (E172), Iron oxide black (E172) (150 mg tablet only).

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma